Gala vs PeterMD: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
PeterMD beats Gala overall, scoring 7.3/10 vs 7/10. Gala is more affordable at $149/mo vs $165/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .
A side-by-side comparison of Gala and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaPeterMD
#29 of 42One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.
Visit PeterMD| Feature | Gala | PeterMD |
|---|---|---|
| Our Score | 7/10 | 7.3/10 |
| Starting Price | $149/mo | $165/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Budget-conscious users looking for the lowest monthly GLP-1 cost |
| Ranking | #40 | #29 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
PeterMD
Pros
- +Flat $165/mo at all dose levels — price doesn't increase as you titrate up to maintenance doses
- +Semaglutide + B12 formulation helps reduce nausea — the most common GLP-1 side effect
- +100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews — strong social proof
- +Video consultations with physicians included — real face-to-face medical oversight
Cons
- −Only available in 42 states — excluded from 8 states, limiting nationwide access
- −Not BBB accredited, with some documented complaints about delayed medication fulfillment
- −Originally a testosterone replacement therapy platform — GLP-1 is an expansion, not the core focus
Our Verdict
PeterMD edges out Gala with a score of 7.3/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to PeterMD's $165/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.